T 1210/20 of 30.11.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T121020.20231130
- Date of decision
- 30 November 2023
- Case number
- T 1210/20
- Petition for review of
- -
- Application number
- 08729939.2
- IPC class
- A01N 33/16A61K 31/655
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- Abstract on EPC2000 Art 083
- Application title
- CANCER TREATMENT METHOD
- Applicant name
- Novartis AG
- Opponent name
- HGF Limited
- Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 83
- Keywords
- Amendments
Sufficiency of disclosure - Catchword
- -
- Citing cases
- T 1261/21
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the
order to maintain the patent on the basis of the claims
according to auxiliary request 1a and a description to
be adapted thereto, where applicable.